Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer
NCT02055170
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class
Stopped
Unable to improve on poor accrual to study.
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG:
finasteride 5mg oral daily
Sponsor
CancerCare Manitoba